CClinicalTrials.gg
Not yet recruitingNCT05225272ERASCsUpdated Sep 18, 2025

Effectiveness of an Enhanced Recovery After Surgery Protocol in Patients Undergoing On-pump Cardiac Surgery

An observational study in Disorder; Heart, Functional, Postoperative, Cardiac Surgery, sponsored by Centre hospitalier de l'Université de Montréal (CHUM). Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-09-18.

Sponsored by Centre hospitalier de l'Université de Montréal (CHUM) · Observational

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
92
Ages
18 Years to 75 Years
Sex
All
01

Study summary

In 2019, the Enhanced Recovery After Surgery (ERAS) Society published recommendations for perioperative care in cardiac surgery. ERAS recommendations included 22 perioperative interventions that may be part of any cardiac Enhanced Recovery Program (ERP). Since that publication, additional perioperative interventions were reported and may be added to a cardiac ERP. Studies on cardiac ERPs report variable benefits on postoperative recovery including lower pain scores, lower opioid consumption and related side effects, shorter intensive care unit and hospital discharge times. At the "Centre Hospitalier de l'Université de Montréal" (CHUM), although most care takers are aware of ERAS recommendations for cardiac surgery patients, adherence to these recommendations is heterogeneous and a cardiac ERP was never implemented.

Read the detailed description

Primary objective: Estimate the effect of implementation of an ERP (including the use of a checklist and teaching of caretakers) on the time needed for patient extubation after on-pump cardiac surgery.

Secondary objective: Estimate the effect of implementation of a ERP (including the use of a checklist and teaching of caretakers) on the need for reintubation, the need to return to the operating room for hemostasis, on pain scores, opioid consumption and related side effects, on the incidence of postoperative delirium in the intensive care unit, on intensive care unit and hospital discharge times, on postoperative complications (stroke, acute renal failure, postoperative atrial fibrillation), and on in-hospital mortality, 30-day mortality and hospital readmission.

The hypothesis of the study is that implementation of an ERP (including the use of a checklist and teaching of caretakers) in patients undergoing on-pump cardiac surgery improves postoperative recovery through shorter extubation time and a reduction of postoperative complications.

Design of the study: single center, bidirectional (prospective and retrospective) chronological cohort study. The adherence to ERP interventions will be measured.

Prospective data will be collected in eligible patients after implementation of a cardiac ERP and compared retrospectively with eligible patients who had surgery in the year before (but not in the four weeks preceding) implementation of the cardiac ERP. In these patients, prospective data is already collected in a quality of care database in cardiac surgery.

The cardiac ERP will be implemented using a checklist designed by cardiac surgeons, anesthesiologists and intensive care specialists. The checklist is based on official ERAS recommendations and other interventions suggested in further studies on ERAS after cardiac surgery. Professionals involved in the perioperative care of cardiac surgery patients will receive specific ERP teachings three weeks and one week before the official implementation of the cardiac ERP. Posters detailing the cardiac ERP will be clearly visible in the cardiac operating rooms and next to the intensive care unit beds to promote adherence.

02

Conditions studied

  • Disorder; Heart, Functional, Postoperative, Cardiac Surgery

Keywords

  • On-pump cardiac surgery
  • Enhanced recovery after surgery
03

In context

Lead sponsor

Centre hospitalier de l'Université de Montréal (CHUM) is the lead sponsor of 370 studies on the registry; 110 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

The investigators aim to conduct a bidirectional cohort study including on-pump cardiac surgery patients. This study will take place at the Centre Hospitalier de l'Université de Montréal (CHUM).

Inclusion criteria

  • On-pump cardiac surgery

Exclusion criteria

Exclusion Criteria:

  • Left Ventricular Ejection Fraction (LVEF) lower than 50%
  • Glomerular filtration rate lower than 50 mL/min
  • Significant pulmonary hypertension (systolic pulmonary artery pressure higher than 65 mmHg)
  • Presence of Intra-aortic balloon pump therapy before surgery
  • Endocarditis surgery
  • An estimated mortality over 8% based on the EuroSCORE II
  • Patients who already had cardiac surgery in the past.
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
92 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients undergoing on-pump cardiac surgery

    The investigators aim to conduct a bidirectional (prospective and retrospective) observational, cohort study including on-pump cardiac surgery patients.

    Other: Enhanced Recovery Program for on-pump cardiac surgery

Interventions

  • OtherEnhanced Recovery Program for on-pump cardiac surgery

    Implementation of a Enhanced Recovery Program for on-pump cardiac surgery patients

06

What researchers measure

Primary outcomes

  1. Time before patient extubation

    Time elapsed between final wound dressing and removal of the endotracheal tube, before and after implementation of the cardiac ERP.

    Time frame: From the end of the surgery to extubation, up to 1 week

Secondary outcomes

  1. Incidence of reintubation

    Need for postoperative endotracheal intubation given the occurrence of respiratory or non-respiratory complication after extubation.

    Time frame: Up to 24 hours after extubation

  2. Acute pain scores using the Numerical Rating Scale (NRS)

    Using the verbal NRS, where 0 means "no pain" and 10 "worst pain imaginable"

    Time frame: 8, 16, 24 and 48 hours after surgery

  3. Opioid consumption

    Opioid consumption converted in intravenous morphine equivalents

    Time frame: 8, 16, 24 and 48 hours after surgery

  4. Opioid side effects

    Including nausea, vomiting, sedation and pruritus

    Time frame: 8, 16, 24 and 48 hours after surgery

  5. Incidence of delirium in the intensive care unit (ICU) using the ICDSC score

    Delirium will be assessed every 8 hours during the ICU stay using the Intensive Care Delirium Screening Checklist (ICDSC). A total ICDSC score greater or equal to 4 has a 99% sensitivity for a psychiatric diagnosis of delirium.

    Time frame: Up to 7 days after surgery or ICU discharge, whichever comes first

  6. Postoperative complications

    Any stroke, acute renal failure (using the Kidney Disease Improving Global Outcomes (KDIGO), new-onset atrial fibrillation (more than 30 minutes or requiring cardioversion)

    Time frame: Up to 7 days after surgery

  7. ICU discharge time

    Time and date when the patient is transferred to ward or step-down unit

    Time frame: At ICU discharge, an average of one day after surgery

  8. Hospital discharge

    Time and date when the patient is discharged from the hospital

    Time frame: At hospital discharge, an average of one week after surgery

  9. In-hospital mortality

    Occurrence of death during hospitalization

    Time frame: At hospital discharge, an average of one week after surgery

  10. 30-day mortality

    Occurrence of death during the first 30 days following surgery

    Time frame: Up to 30 days after surgery

  11. Hospital readmission

    Need for readmission following discharge after index surgery

    Time frame: Up to 30 days after surgery

07

Study locations

1 site
  • Centre Hospitalier de l'Université de Montréal (CHUM)
    Montreal, Quebec H2X 0A9, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05225272
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Responsible party
Sponsor
First posted
Feb 4, 2022
Start date
Sep 1, 2026 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Sep 18, 2025

Study contacts

Alex Moore, MD, FRCPC
Contact
alex.moore@umontreal.ca
514-890-8000 ext. 12132
Julie Desroches, PhD
Contact
anesthesie.recherche.chum@ssss.gouv.qc.ca
514-890-8000 ext. 24542
Alex Moore, MD, FRCPC
principal investigator · Centre hospitalier de l'Université de Montréal (CHUM)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion